REZUBIO

REZUBIO is a targeted drug developer with research directions including areas such as oncology, immunology, and metabolic diseases. Its technical expertise mainly lies in the development of tissue-specific targeting molecules, such as liver- and intestine-targeted drugs, to achieve a differentiated advantage of high efficacy and low side effects.